drugset / Trial / NCT01471353
Sorafenib Plus Capecitabine (SorCape) in Previously Treated Metastatic Colorectal Cancer
NaSingle-groupOpen-labelTreatment
Summary
Combining Sorafenib with standard cytotoxic fluoropyrimidine therapy for advanced colorectal cancer may provide clinical benefit when no other treatment remains.
Timeline
- Start
- 2011-11
- Primary completion
- 2015-10
- Completion
- 2017-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capecitabine | Small molecule | 1000 mg/m2 | Oral |
| Subject | Sorafenib | Small molecule | 200 mg | Oral |
| Subject | Sorafenib | Small molecule | 400 mg | Oral |